||Sep 2, 2004
NEW HAVEN, Conn. September 2, 2004 Achillion
Pharmaceuticals, Inc., a leader in the discovery and development of small molecule
drugs to combat the most challenging of infectious diseases, today announced
the appointment of Michael D. Kishbauch as Chief Executive Officer. Mr. Kishbauch
replaces interim CEO, Marios Fotiadis. Ac...